Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 8:18 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 331 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Observational data collection Clear all

Conditions: Human Immunodeficiency Virus, Human Papillomavirus-Related Anal Squamous Cell Carcinoma, High-Grade Squamous Intraepithelial Lesions
Interventions: Biospecimen Collection, Questionnaires; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years and older
Enrollment: 217 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: COVID - 19
Interventions: FDA approved mRNA vaccines; Biological
Lead sponsor: Biomedical Advanced Research and Development Authority; Federal
Eligibility: 3 Years and older
Enrollment: 2,519 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 20
States / cities: Kissimmee, Florida • Chicago, Illinois • Oak Park, Illinois + 15 more

Conditions: Heart Arrest
Interventions: Respiratory & Heart Rate Data Collection; Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 133 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Pulmonary Hypertension of Newborn
Interventions: INOmax; Drug
Lead sponsor: Mallinckrodt; Industry
Eligibility: 27 Weeks to 40 Weeks
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 30
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Loma Linda, California + 27 more

Conditions: Chronic Heart Failure, CKD Stage 3
Interventions: AquaPass System; Device
Lead sponsor: AquaPass Medical Ltd.; Industry
Eligibility: 21 Years to 79 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 8
States / cities: La Jolla, California • San Francisco, California • Minneapolis, Minnesota + 5 more

Conditions: Breast Carcinoma
Interventions: Interview; Other
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Cardiovascular Diseases, Cardiac Arrhythmia, Atrial Fibrillation
Interventions: Screening, detection and referral for atrial fibrillation; Device
Lead sponsor: American Pharmacists Association Foundation; Other
Eligibility: 18 Years and older
Enrollment: 650 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Mental Disorders, Behavior Disorders
Interventions: Recovery Roadmap (RR) Wave 1, Recovery Roadmap (RR) Wave 2; Behavioral
Lead sponsor: Center for Social Innovation, Massachusetts; Other
Eligibility: 18 Years and older
Enrollment: 127 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Needham, Massachusetts

Conditions: PHYSIOLOGICAL PHENOMENA, Homeostasis, Physical Functional Performance, Cardiorespiratory Fitness, Cardiometabolic Risk Factors, Mobility Limitation
Interventions: Standardized Physiologic Resilience Challenge, Multimodal Whole-Body Physiologic Monitoring, Research-Only Whole-Body Digital Twin Analysis; Procedure · Other
Lead sponsor: Truway Health, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2041
U.S. locations: 1
States / cities: New York, New York

Conditions: Odontalgia, Toothache
Interventions: Epidiolex 100 mg/mL Oral Solution, Placebo; Drug
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 75 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Prostate Carcinoma
Interventions: Laboratory Biomarker Analysis, Medical Examination Assessment, Screening Questionnaire Administration; Other · Procedure
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 55 Years to 74 Years · Male only
Enrollment: 76,685 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1993 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Kidney Transplant Rejection
Interventions: Prospera; Diagnostic Test
Lead sponsor: Natera, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 55
States / cities: Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 45 more

Conditions: Obesity-Related Malignant Neoplasm
Interventions: Discussion, Interview, Survey Administration; Behavioral · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Not listed
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Respiratory Failure, Interstitial Lung Disease, Lung Diseases
Interventions: Patient Biospecimen Registry (observational and blood sampling); Other
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: AMN, AMN Gene Mutation, X-ALD
Interventions: Natural History Observation; Other
Lead sponsor: SwanBio Therapeutics, Inc.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 4
States / cities: Stanford, California • Boston, Massachusetts • New York, New York + 1 more

Conditions: Substance Use Disorder
Interventions: MRI: Brain Imaging Data Collection; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 45 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Myeloma
Interventions: Telephone Questionnaire; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 78 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: BPD - Bronchopulmonary Dysplasia
Interventions: No interventions or procedures; Other
Lead sponsor: Pediatrix; Other
Eligibility: Not listed
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Heart Failure
Interventions: Increased Intravenous Bolus Loop Diuretic Dose (Bumetanide or Furosemide), IV Chlorothiazide; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 458 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Bronchiolitis Obliterans Syndrome (BOS)
Interventions: Extracorporeal Photopheresis (ECP), No intervention in the SOC / Retrospective Chart review.; Combination Product · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2028
U.S. locations: 22
States / cities: Birmingham, Alabama • Phoenix, Arizona • La Jolla, California + 18 more

Conditions: Dementia
Interventions: Nutrition Status; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: On-site Practice Assessment, Clinical Staff Questionnaires, Patient Opinion Surveys, Modular online COPD Education, COPD in Primary Care/CAPTURE Introduction Focus Groups; Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: Not listed
Enrollment: 196 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 6
States / cities: Los Angeles, California • Aurora, Colorado • Miami, Florida + 3 more

Conditions: Spinal Cord Stimulation
Interventions: Spinal Cord Stimulation (SCS) Trial; Procedure
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Non-small Cell Lung Cancer Metastatic
Interventions: Predictive models (data collection); Other
Lead sponsor: Sophia Genetics SAS; Industry
Eligibility: 18 Years and older
Enrollment: 4,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 6
States / cities: Iowa City, Iowa • Worcester, Massachusetts • Rochester, Minnesota + 3 more

Search by objective public record fields.

Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)

Retail COVID-19 Study

Automated Respiration Rate to Improve Accuracy of the Electronic Cardiac Arrest Risk Triage Score (eCART) Algorithm

Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension

Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System

Stakeholder Assessment of Implementing the Commission on Cancer Operative Standards for Cancer Surgery

Solutions for Atrial Fibrillation Edvocacy (SAFE)

Recovery Roadmap Phase II Small Business Innovation Research Grant

Truway Whole-Body Digital Twin and Physiologic Resilience Study (TRU-OMNIBODY)

CBD for Dental Pain

Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)

The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)

Self-monitoring Focus Groups With Vibrant Lives Pasadena Participants

Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research

Study of Disease Progression in Adults With Inherited Forms of Spastic Paraplegia

Functional Connectivity Changes During Early Recovery as a Marker for Relapse

Long-Term Follow Up Study for AMD3100 Patients

Impact of Steroid, Diuretic, and Fluid Use on BPD Outcomes

Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure

Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts

Assessment of DeMentia Nutrition Intervention Needs Among Care Recipients and carEgivers

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 2)

Prospective Evaluation of the Optimal SCS Trial Length

Predictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung Cancer